The Business Research Company’s report on the Liver Disease Diagnostics Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the liver disease diagnostics market’s growth in recent years?
The increase in alcohol consumption is expected to propel the growth of the liver disease diagnostics market going forward. Alcohol consumption is increasing due to factors such as changing social norms, greater affordability, widespread availability, and rising stress or mental health challenges. Liver disease diagnostics are crucial in monitoring the impact of alcohol consumption on liver health, helping to detect early signs of liver damage such as fatty liver, hepatitis, or cirrhosis. For instance, in December 2022, according to the National Health Service, an England-based government department, the percentage of people who consumed alcohol in the past 12 months rose with age, starting at 62% among those aged 16 to 24, reaching 85% for individuals aged 55 to 74. Therefore, the increase in alcohol consumption is driving the growth of the liver disease diagnostics market.
Access Your Free Sample of the Global Liver Disease Diagnostics Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp
How does the future projection of the liver disease diagnostics market size compare to its historical growth?
The liver disease diagnostics market size has grown strongly in recent years. It will grow from $36.26 billion in 2024 to $39.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the growing prevalence of both acute and chronic liver conditions, increasing prevalence of liver diseases, increasing consumption of alcohol, rising awareness towards liver health, and expanding healthcare infrastructure.
The liver disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $52.04 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to an increase in the geriatric population, rising research & development spending, an increasing number of biopsy procedures and diseases, and expanding telemedicine adoption. Major trends in the forecast period include the rise of personalized medicine, technological advancements in diagnostic kits, advancements in rapid tests, technological advancement in the healthcare sector, and technological advancements in diagnostic methods.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp
Which key players are shaping the future of the liver disease diagnostics market?
Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc
What trends will propel the growth and evolution of the liver disease diagnostics market?
Major companies operating in the liver disease diagnostics market are focusing on developing innovative solutions, such as non-invasive tools for liver assessment, to develop more accurate and efficient diagnostic methods. A non-invasive tool for liver assessment refers to diagnostic methods that evaluate liver conditions using techniques like elastography or blood tests, avoiding the need for invasive procedures like biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool for liver assessment, aimed at early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology allows for rapid and accurate measurements of liver stiffness and fat content without the need for invasive procedures like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, involving the placement of a probe on the skin over the liver. The probe emits sound waves, which measure liver tissue stiffness, helping assess fibrosis or scarring.
Which regions are expected to become dominant players in the liver disease diagnostics market?
North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report
What are the emerging key segments in the liver disease diagnostics market, and how are they evolving?
The liver disease diagnostics market covered in this report is segmented –
1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques
2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases
3) By End Users: Hospitals, Laboratories, Other End Users
Subsegments:
1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests
2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)
3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy
4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy
5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862
How is the liver disease diagnostics market defined?
Liver disease diagnostics refer to the medical procedures and tests used to identify and assess various liver conditions, including liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods often involve blood tests to check liver enzyme levels, imaging techniques like ultrasound or CT scans, and sometimes biopsy procedures to obtain tissue samples.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
